The clinical characteristics and antiretroviral dosing patterns of HIV-infected patients receiving dialysis

This publication has 22 references indexed in Scilit:

• Changing Trends in the Survival of Dialysis Patients with Human Immunodeficiency Virus in the United States
  Journal of the American Society of Nephrology, 2002
• Protease inhibitors are associated with a slowed progression of HIV-related renal diseases
  Clinical Nephrology, 2002
• Nephropathy and Establishment of a Renal Reservoir of HIV Type 1 during Primary Infection
  New England Journal of Medicine, 2001
• Highly active antiretroviral therapy improves survival of HIV-infected hemodialysis patients
  American Journal of Kidney Diseases, 2000
• HIV-1-associated nephropathy and response to highly-active antiretroviral therapy
  The Lancet, 1998
• A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less
  New England Journal of Medicine, 1997
• Captopril and renal survival in patients with human immunodeficiency virus nephropathy
  American Journal of Kidney Diseases, 1996
• Predictors of Survival in HIV-Infected Patients on Hemodialysis
  American Journal of Nephrology, 1996
• Nephropathy Associated with Infection by Human Immunodeficiency Virus: A Report on 11 Cases Including 6 Treated with Zidovudine
  Nephron, 1992
• Outcome of patients with human immunodeficiency virus on maintenance hemodialysis
  Kidney International, 1988